packageIcatibant

icatibant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Icatibant is a bradykinin B2 receptor antagonist used to treat hereditary angioedema attacks. It is authorised in the European Union and used for this condition.

Summary written by glm-5.3-flash from Wikidata Q902379 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:icatibant
ATC codes:B06AC02
DrugBank:DB06196
PubChem CID:71364
ChEBI:68556
Wikidata:Q902379
molar mass:1304.5 g/mol (Drugs.Common 25.09, not verified)
logP:-6.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown